Glucagon-like peptide-1 (GLP-1) is a hormone naturally created by the small intestine that triggers insulin release from the pancreas, manages blood sugar levels, slows stomach emptying during digestion, and increases satiety (feeling of fullness) after eating
The company said the FDA based its approval on results from a Phase 3 trial of more than 300 adults with obesity
3 Together, they address both parts of the lipid profile
It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities
If youve been GLP-curious, and discouraged - youre not wrong
Clinical research shows Ipamorelin is approximately 13 times more selective than GHRP-6, with a half-life of about 2 hours